Samir Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -37.89%
- Profit Growth -53.68%
- Ebitda 27.28%
- Net Worth 0.75%
- Total Assets -1.58%
About Samir Biotech
Samir Biotech Pvt Ltd (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 August 1995 and has a history of 29 years and five months. Its registered office is in Delhi, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Gaba and Radhika Gaba serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1995PTC071825
-
Company No.
071825
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Aug 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Who are the key members and board of directors at Samir Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Gaba
|
Director | 01-Mar-2013 | Current |
|
Radhika Gaba
|
Director | 14-Aug-2014 | Current |
Financial Performance of Samir Biotech.
Samir Biotech Pvt Ltd, for the financial year ended 2019, experienced significant reduction in revenue, with a 37.89% decrease. The company also saw a substantial fall in profitability, with a 53.68% decrease in profit. The company's net worth moved up by a moderate rise of 0.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samir Biotech?
In 2019, Samir Biotech had a promoter holding of 68.60% and a public holding of 31.41%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nvr Agritech Private LimitedNarendra Gaba and Radhika Gaba are mutual person
-
Jabalpur Forestry Private Limited
Narendra Gaba is a mutual person
-
Protagon Biotech Private Limited
Narendra Gaba is a mutual person
-
Vat Solutions Private Limited
Narendra Gaba is a mutual person
-
Graduate Portfolio Limited
Narendra Gaba and Radhika Gaba are mutual person
-
Investrekk Global Research Private Limited
Narendra Gaba is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Samir Biotech?
Unlock and access historical data on people associated with Samir Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samir Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samir Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.